Search alternatives:
significant adverse » significant advantage (Expand Search), significant decrease (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
adverse decrease » rivers decreased (Expand Search)
based based » based case (Expand Search), based basis (Expand Search), ranked based (Expand Search)
significant adverse » significant advantage (Expand Search), significant decrease (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
adverse decrease » rivers decreased (Expand Search)
based based » based case (Expand Search), based basis (Expand Search), ranked based (Expand Search)
-
41
Table2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX
Published 2024“…Among the factors significantly influencing oxaliplatin-related neurological adverse events, male sex and combination medication decreased the risk of neurological adverse events, while higher cumulative dose increased the risk.…”
-
42
Table3_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.XLSX
Published 2024“…Among the factors significantly influencing oxaliplatin-related neurological adverse events, male sex and combination medication decreased the risk of neurological adverse events, while higher cumulative dose increased the risk.…”
-
43
Image2_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG
Published 2024“…Among the factors significantly influencing oxaliplatin-related neurological adverse events, male sex and combination medication decreased the risk of neurological adverse events, while higher cumulative dose increased the risk.…”
-
44
Image1_Neurological adverse events associated with oxaliplatin: A pharmacovigilance analysis based on FDA adverse event reporting system.JPEG
Published 2024“…Among the factors significantly influencing oxaliplatin-related neurological adverse events, male sex and combination medication decreased the risk of neurological adverse events, while higher cumulative dose increased the risk.…”
-
45
Description of residence-based (RB) and mobility-based (MB) environmental factors and significance levels of the Mann-Whitney U test.
Published 2024“…<p>Description of residence-based (RB) and mobility-based (MB) environmental factors and significance levels of the Mann-Whitney U test.…”
-
46
Funnel plot, using data from 3 trials of adverse events in MSCs therapy group and control group.
Published 2023Subjects: -
47
-
48
-
49
Matrix of significance for the MMD values based on the relationship MMD>2SD.
Published 2023“…<p>Matrix of significance for the MMD values based on the relationship MMD>2SD.…”
-
50
Statistical summary of the two significant ROIs identified by ROI-based inference.
Published 2025“…<p>Statistical summary of the two significant ROIs identified by ROI-based inference.</p>…”
-
51
-
52
-
53
Significant genes identified in the gene-based test with GWAS summary data.
Published 2025“…<p>Significant genes identified in the gene-based test with GWAS summary data.…”
-
54
-
55
Key signals of change by LHZ based on most significant systematic transitions.
Published 2024“…<p>Key signals of change by LHZ based on most significant systematic transitions.…”
-
56
-
57
-
58
-
59
-
60
Independent variants with a meta-analysis genome-wide significant association with Horvath-based or Hannum-based epigenetic age acceleration.
Published 2019“…<p>Independent variants with a meta-analysis genome-wide significant association with Horvath-based or Hannum-based epigenetic age acceleration.…”